New York Life Investment Management LLC Immunity Bio, Inc. Transaction History

New York Life Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$1.25 - $5.21 $5,510 - $22,965	-4,408 Reduced 2.25%	191,221 $959,000
Q3 2023 Nov 07, 2023	SELL	$1.29 - $3.1 $39,755 - $95,535	-30,818 Reduced 13.61%	195,629 $330,000
Q2 2023 Aug 04, 2023	SELL	$1.53 - $6.41 $55,090 - $230,804	-36,007 Reduced 13.72%	226,447 $629,000
Q1 2023 May 08, 2023	BUY	$1.35 - $4.78 $354,312 - $1.25 Million	262,454 New	262,454 $477,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.